| Data | Hora | Fonte | Título | Código | Companhia |
| 13/04/2012 | 18:11 | Edgar (US Regulatory) | Amended Annual Statement of Changes in Beneficial Ownership (5/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/04/2012 | 12:26 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/04/2012 | 09:15 | Zacks | Allos Eyed by Spectrum Pharma - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/04/2012 | 06:06 | Zacks | Company News for April 9, 2012 - Corporate Summary | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/04/2012 | 07:07 | Edgar (US Regulatory) | Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/04/2012 | 07:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 18:23 | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 15:07 | Dow Jones News | UPDATE: Amid Setback, Spectrum Pharma To Buy Allos For $206 Million | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 11:28 | PR Newswire (US) | Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum ... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 09:52 | PR Newswire (US) | Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger w... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2012 | 08:00 | Business Wire | Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/03/2012 | 05:14 | Zacks | Zacks #1 Rank Additions for Friday - Tale of the Tape | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/03/2012 | 07:03 | Edgar (US Regulatory) | Amended Quarterly Report (10-Q/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 22/03/2012 | 07:00 | Zacks | Allos Upped to Outperform - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/03/2012 | 05:15 | Zacks | Allos Narrows Loss - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/03/2012 | 18:00 | Business Wire | Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/03/2012 | 20:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2012 | 19:48 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/02/2012 | 21:19 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 21/02/2012 | 11:00 | Business Wire | Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 14/02/2012 | 18:33 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 14/02/2012 | 13:43 | Edgar (US Regulatory) | Schedule 13G | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/02/2012 | 13:59 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/02/2012 | 15:46 | Zacks | ALTH Seeks Review of Folotyn Verdict - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/01/2012 | 11:30 | Business Wire | Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/01/2012 | 11:00 | Business Wire | Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/01/2012 | 10:00 | Zacks | European Setback for Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/01/2012 | 10:43 | Business Wire | Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/01/2012 | 15:15 | Zacks | Allos Therapeutics Cut to Neutral - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/01/2012 | 11:15 | Zacks | AMAG Q4 Sales Set to Disappoint - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |